Form 4 Filing for Arcutis Biotherapeutics, Inc. - Amit Munshi

This filing details transactions by Amit Munshi, a director at Arcutis Biotherapeutics, Inc. On June 5, 2026, Mr. Munshi acquired 5,778 shares of Common Stock and was granted 16,667 Stock Options. The Common Stock acquisition, valued at $0, is related to Restricted Stock Units (RSUs) granted in connection with his role as a non-employee director. These RSUs vest on the earlier of the first anniversary of the grant date or immediately before the next annual meeting, contingent upon continued service. The Stock Options also vest under similar conditions, becoming exercisable on the same terms as the RSUs. The exercise price for the options is $21.23 per share, and they expire on June 5, 2036. Following these transactions, Mr. Munshi holds 9,799 shares of Common Stock directly and has 16,667 Stock Options outstanding.